The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health

• Published in: International journal of molecular sciences 2021-03, Vol.22 (6), p.3253
• Main Authors: Roblin, Clarisse, Chiumento, Steve, Jacqueline, Cédric, Pinloche, Eric, Nicoletti, Cendrine, Olleik, Hamza, Courvoisier-Dezord, Elise, Amouric, Agnès, Basset, Christian, Dru, Louis, Ollivier, Marie, Bogey-Lambert, Aurélie, Vidal, Nicolas, Atta, Mohamed, Maresca, Marc, Devillard, Estelle, Duarte, Victor, Perrier, Josette, Lafond, Mickael
• Format: Article
• Language: English
• Subjects: Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; antibiotics; Antifungal Agents - pharmacology; antimicrobial resistance; Bacteriocins - chemistry; Bacteriocins - pharmacology; Bacteriology; Biochemistry, Molecular Biology; Biofilms - drug effects; Clostridiales - metabolism; Clostridium Infections - drug therapy; Clostridium Infections - microbiology; Clostridium perfringens - drug effects; Human health and pathology; Humans; Infectious diseases; Life Sciences; Medication; Microbiology and Parasitology; Peptides - chemistry; Peptides - pharmacology; peritonitis infection; Pharmaceutical sciences; Protein Processing, Post-Translational; RiPP; Ruminococcus gnavus E1; sactipeptide
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22063253

The world is on the verge of a major antibiotic crisis as the emergence of resistant bacteria is increasing, and very few novel molecules have been discovered since the 1960s. In this context, scientists have been exploring alternatives to conventional antibiotics, such as ribosomally synthesized and post-translationally modified peptides (RiPPs). Interestingly, the highly potent in vitro antibacterial activity and safety of ruminococcin C1, a recently discovered RiPP belonging to the sactipeptide subclass, has been demonstrated. The present results show that ruminococcin C1 is efficient at curing infection and at protecting challenged mice from with a lower dose than the conventional antibiotic vancomycin. Moreover, antimicrobial peptide (AMP) is also effective against this pathogen in the complex microbial community of the gut environment, with a selective impact on a few bacterial genera, while maintaining a global homeostasis of the microbiome. In addition, ruminococcin C1 exhibits other biological activities that could be beneficial for human health, as well as other fields of applications. Overall, this study, by using an in vivo infection approach, confirms the antimicrobial clinical potential and highlights the multiple functional properties of ruminococcin C1, thus extending its therapeutic interest.